Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

The New York Times – Business:

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Brazil, Children and Childhood, Disabilities, Drugs (Pharmaceuticals), Genetic Engineering, Genetics and Heredity, Medicine and Health, Novartis AG, Spinal Muscular Atrophy, Suits and Litigation (Civil)
←Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
Judge To Hold Hearing Over Georgia Special Grand Jury Report→

More posts

  • We’re pediatricians who vaccinated our children and grandchildren. Trust us over Trump.

  • Ocasio-Cortez surpasses Newsom as 2028 Dem presidential favorite on Polymarket

  • Rubio, Bessent stayed behind as Trump secretly switched planes over alleged Iran threat

  • Students wait for A-level, T-level and BTec results

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube